Palatin Technologies
PTN
$1.72
Share price
-0.58%
Change (1 day)
-26.81%
Change (1 year)
Categories
EPS for Palatin Technologies (PTN)
EPS in 2023 (TTM): -$2.96
According to Palatin Technologies's latest financial reports the company's current EPS (TTM) is -$2.96. In 2022 the company made an earnings per share (EPS) of -$3.13 an increase over its 2021 EPS that were of -$3.66.
EPS history for Palatin Technologies from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.96 | -5.43% |
| 2022 | -$3.13 | -14.48% |
| 2021 | -$3.66 | 33.09% |
| 2020 | -$2.75 | -161.11% |
| 2019 | $4.50 | -4909.03% |
| 2018 | -$0.09357 | -102.88% |
| 2017 | $3.25 | -143.33% |
| 2016 | -$7.50 | -9.09% |
| 2015 | -$8.25 | 3200% |
| 2014 | -$0.25 | -93.33% |
| 2013 | -$3.75 | -69.39% |
| 2012 | -$12.25 | 10.16% |
| 2011 | -$11.12 | -58.04% |
| 2010 | -$26.50 | -394.44% |
| 2009 | $9.00 | -121.18% |
| 2008 | -$42.50 | -10.53% |
| 2007 | -$47.50 | -57.78% |
| 2006 | -$112.50 | 9.76% |
| 2005 | -$102.50 | 5.13% |
| 2004 | -$97.50 | -35% |
| 2003 | -$150.00 | -38.14% |
| 2002 | -$242.50 | -15.65% |
| 2001 | -$287.50 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -575.85% | 🇺🇸 USA |
 AstraZeneca AZN | $1.98 | -167.06% | 🇬🇧 UK |
 Neurocrine Biosciences
NBIX | $1.96 | -166.22% | 🇺🇸 USA |
 MediciNova MNOV | -$0.25 | -91.55% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $1.57 | -153.04% | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | -$0.47 | -84.12% | 🇺🇸 USA |
 GlycoMimetics
GLYC | -$0.65 | -78.04% | 🇺🇸 USA |
 Ardelyx ARDX | -$0.12 | -95.95% | 🇺🇸 USA |